Anzeige
Mehr »
Samstag, 28.02.2026 - Börsentäglich über 12.000 News
Wegweisende News: NurExone - Pionier der regenerativen neuronalen Medizin!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A411DW | ISIN: CA81752F1062 | Ticker-Symbol: PSH0
Tradegate
27.02.26 | 18:28
0,082 Euro
-4,68 % -0,004
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
SERNOVA BIOTHERAPEUTICS INC Chart 1 Jahr
5-Tage-Chart
SERNOVA BIOTHERAPEUTICS INC 5-Tage-Chart
RealtimeGeldBriefZeit
0,0800,09113:04
0,0800,09127.02.

Aktuelle News zur SERNOVA BIOTHERAPEUTICS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
20.02.Sernova Biotherapeutics Inc: Sernova to extend, reduce price of warrants30
20.02.Sernova to amend warrants, extend expiry, and cut exercise price19
20.02.Sernova Biotherapeutics: Sernova Biotherapeutics Announces Warrant Amendments577Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - February 20, 2026) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("the Company"), a leading regenerative medicine company...
► Artikel lesen
09.12.25Sernova Biotherapeutics Inc: Sernova sued by former CFO Swetlow181
13.11.25Sernova Biotherapeutics Inc: Sernova closes $874,600 first tranche of placement99
13.11.25Sernova Biotherapeutics Closes First Tranche of a Private Placement of Equity Financing to Support Ongoing Clinical Efforts803Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - November 13, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTC: SEOVF) (FSE: PSH) ("Sernova or the Company)") a leading regenerative medicine...
► Artikel lesen
SERNOVA BIOTHERAPEUTICS Aktie jetzt für 0€ handeln
01.10.25Sernova Biotherapeutics Inc: Sernova converts debt of $13.3-million into units114
01.10.25Stocks in Play: Sernova Biotherapeutics54
01.10.25Sernova converts $13.3M debt to equity ahead of clinical milestone49
01.10.25Sernova Biotherapeutics Announces $13 Million Debt-to-Equity Conversion Eliminating Significant Financing Overhang637Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - October 1, 2025) - Sernova Biotherapeutics (TSX: SVA) (OTCQB: SEOVF) (FSE: PSH0) ("Sernova") a leading regenerative medicine company focused...
► Artikel lesen
23.09.25Sernova Biotherapeutics Inc: Sernova Biotherapeutics appoints Brooks chairman35
23.09.25Sernova Corp.: Sernova Biotherapeutics Appoints John L. Brooks III, Former Chair and CEO of Joslin Diabetes Research Center, as Chair of the Board of Directors32
08.09.25Sernova Corp.: Sernova Biotherapeutics to Participate in the H.C. Wainwright 27th Annual Global Investor Conference77
09.07.25Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Announces Collaboration with Eledon Pharmaceuticals to Advance a Potential Functional Cure for Type 1 Diabetes1.405LONDON, Ontario, July 09, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics ("Sernova") (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH) today announced a Collaborative Research Agreement with Eledon Pharmaceuticals...
► Artikel lesen
02.06.25Sernova Biotherapeutics, Inc.: Sernova Appoints Jonathan Rigby as Interim Chair447LONDON, Ontario and BOSTON, June 02, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
► Artikel lesen
02.06.25Original-Research: Sernova Biotherapeutics Inc (von First Berlin Equity Research GmbH): Buy965Original-Research: Sernova Biotherapeutics Inc - from First Berlin Equity Research GmbH 02.06.2025 / 13:39 CET/CEST Dissemination of a Research, transmitted by EQS News - a service of EQS Group....
► Artikel lesen
26.05.25Sernova Biotherapeutics, Inc.: Chair of Sernova Biotherapeutics Resigns455LONDON, Ontario and BOSTON, May 26, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing its...
► Artikel lesen
10.03.25Sernova Biotherapeutics, Inc.: Sernova Biotherapeutics Appoints Pericles Calias, Ph.D. as Chief Development Officer and Head of R&D528LONDON, Ontario and BOSTON, March 10, 2025 (GLOBE NEWSWIRE) -- Sernova Biotherapeutics, (TSX: SVA) (OTCQB: SEOVF) (FSE/XETRA: PSH), a leading regenerative medicine company focused on developing it's...
► Artikel lesen
18 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,14